scispace - formally typeset
H

Helen Turley

Researcher at University of Oxford

Publications -  141
Citations -  17417

Helen Turley is an academic researcher from University of Oxford. The author has contributed to research in topics: Angiogenesis & Vascular endothelial growth factor. The author has an hindex of 65, co-authored 141 publications receiving 16466 citations. Previous affiliations of Helen Turley include John Radcliffe Hospital & Russian Academy.

Papers
More filters
Journal Article

Hypoxia-inducible Expression of Tumor-associated Carbonic Anhydrases

TL;DR: A new class of HIF-1-responsive gene is defined, the activation of which has implications for the understanding of hypoxic tumor metabolism and which may provide endogenous markers for tumor hypoxia.
Journal ArticleDOI

The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages

TL;DR: In the majority of solid tumors examined, including bladder, brain, breast, colon, ovarian, pancreatic, prostate, and renal carcinomas, nuclear expression of HIF-1α and -2α was observed in varying subsets of the tumor cells.
Journal ArticleDOI

Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor *

TL;DR: It is shown using suppression by small interference RNA that each of the three PHD isoforms contributes in a non-redundant manner to the regulation of both Hif-1α and HIF-2α subunits and that the contribution of each PHD under particular culture conditions is strongly dependent on the abundance of the enzyme.
Journal ArticleDOI

bcl-2 Protein in Non-Small-Cell Lung Carcinoma

TL;DR: The proto-oncogene bcl-2 is abnormally expressed in some lung carcinomas, and its expression may have prognostic importance.
Journal ArticleDOI

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

TL;DR: It is concluded that HIF1α and HIF2α overexpression is a common event in NSCLC, which is related to the up-regulation of various angiogenic factors and with poor prognosis.